quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:05:00·1501d
PRRelease
CM Life Sciences, Inc. logo
Sema4 Holdings Corp. logo

Sema4 Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights

CMLF· CM Life Sciences, Inc.SMFR· Sema4 Holdings Corp.
FinanceTechnology
Original source

Companies

  • CMLF
    CM Life Sciences, Inc.
    Finance
  • SMFR
    Sema4 Holdings Corp.
    Technology

Recent analyst ratings

  • Dec 7SMFRUpdateGoldman$1.00
  • Aug 16SMFRUpdateJefferies$2.00
  • Jun 2SMFRUpdateGoldman$3.50
  • Nov 19SMFRUpdateGoldman Sachs$12.00
  • Oct 8SMFRUpdateBTIG Research$12.00
  • Sep 30SMFRUpdateCowen & Co.$13.00

Related

  • 13D/G804d
    SEC Form SC 13G filed by Sema4 Holdings Corp.
  • INSIDER821d
    Saad Kareem sold $625 worth of shares (193 units at $3.24) and converted options into 546 shares, increasing direct ownership by 1% to 24,467 units (SEC Form 4)
  • INSIDER832d
    Ryan Jason gifted 73,614 shares, closing all direct ownership in the company (SEC Form 4)
  • SEC837d
    Sema4 Holdings Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits
  • INSIDER840d
    Saad Kareem sold $271 worth of shares (105 units at $2.58), decreasing direct ownership by 0.43% to 24,114 units (SEC Form 4)
  • INSIDER841d
    Saad Kareem converted options into 273 shares, increasing direct ownership by 1% to 24,219 units (SEC Form 4)
  • INSIDER841d
    Ryan Jason converted options into 67,780 shares, increasing direct ownership by 1,162% to 73,614 units (SEC Form 4)
  • INSIDER856d
    Stueland Katherine converted options into 18,750 shares and sold $25,338 worth of shares (11,734 units at $2.16), increasing direct ownership by 15% to 52,578 units (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022